About: Estimation of molecular upper remission limit for monitoring minimal residual disease in peripheral blood of acute myeloid leukemia patients by WT1 expression

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Estimation of molecular upper remission limit for monitoring minimal residual disease in peripheral blood of acute myeloid leukemia patients by WT1 expression Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
rdfs:seeAlso	http://dx.doi.org/10.3892/etm.2011.363
Description	Monitoring of WT1 expression by quantitative PCR in patients with AML has been shown as a suitable marker of minimal residual disease. The WT1 expression correlated with clinical outcome and as a border of molecular relapse was determined the upper remission limit of WT1 expression. Monitoring of WT1 expression by quantitative PCR in patients with AML has been shown as a suitable marker of minimal residual disease. The WT1 expression correlated with clinical outcome and as a border of molecular relapse was determined the upper remission limit of WT1 expression. (en)
Title	Estimation of molecular upper remission limit for monitoring minimal residual disease in peripheral blood of acute myeloid leukemia patients by WT1 expression Estimation of molecular upper remission limit for monitoring minimal residual disease in peripheral blood of acute myeloid leukemia patients by WT1 expression (en)
skos:prefLabel	Estimation of molecular upper remission limit for monitoring minimal residual disease in peripheral blood of acute myeloid leukemia patients by WT1 expression Estimation of molecular upper remission limit for monitoring minimal residual disease in peripheral blood of acute myeloid leukemia patients by WT1 expression (en)
skos:notation	RIV/00023736:_____/12:00009420!RIV12-MZ0-00023736
http://linked.open...avai/predkladatel	Ústav hematologie a krevní transfúze
http://linked.open...avai/riv/aktivita	P Z
http://linked.open...avai/riv/aktivity	P(NS10632), Z(MZ0UHKT2005)
http://linked.open...iv/cisloPeriodika	1
http://linked.open...vai/riv/dodaniDat	2012
http://linked.open...aciTvurceVysledku	Schwarz, Jiří Šálek, Cyril Marková, Jana Soukupová Maaloufová, Jacqueline Haškovec, Cedrik Polák, Jaroslav Hájková, Hana
http://linked.open.../riv/druhVysledku	J - Článek v odborném periodiku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Ústav hematologie a krevní transfúze
http://linked.open...dnocenehoVysledku	134789
http://linked.open...ai/riv/idVysledku	RIV/00023736:_____/12:00009420
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	Wilms tumor gene; acute myeloid leukemia; minimal residual disease; prognosis; relapse (en)
http://linked.open.../riv/klicoveSlovo	relapse acute myeloid leukemia Wilms tumor gene prognosis minimal residual disease
http://linked.open...odStatuVydavatele	GR - Řecká republika
http://linked.open...ontrolniKodProRIV	[D19FBE5DCE4A]
http://linked.open...i/riv/nazevZdroje	Experimental and Therapeutic Medicine
http://linked.open...in/vavai/riv/obor	FD
http://linked.open...ichTvurcuVysledku	7 (xsd:int)
http://linked.open...cetTvurcuVysledku	7 (xsd:int)
http://linked.open...vavai/riv/projekt	New molecular markers for monitoring of residual disease in acute myeloid leukemia patients
http://linked.open...UplatneniVysledku	2012
http://linked.open...v/svazekPeriodika	3
http://linked.open...iv/tvurceVysledku	Marková, Jana Polák, Jaroslav Schwarz, Jiří Šálek, Cyril Haškovec, Cedrik Hájková, Hana Maaloufová-Soukupová, Jacqueline
http://linked.open...ain/vavai/riv/wos	000298124900023
http://linked.open...n/vavai/riv/zamer	Význam molekulárně biologických vyšetření pro objasnění patogeneze a pro diagnostiku poruch krvetvorby a využití krvetvorné buňky v léčbě onemocnění krvetvorby a jiných tkání.
issn	1792-0981
number of pages	5 (xsd:int)
http://bibframe.org/vocab/doi	10.3892/etm.2011.363
is http://linked.open...avai/riv/vysledek of	Estimation of molecular upper remission limit for monitoring minimal residual disease in peripheral blood of acute myeloid leukemia patients by WT1 expression

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 35 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software